Oropouche Virus

Virological Characteristics

The Oropuche virus genome consists of three single stranded negative sense RNA segments: large (L), medium (M), and small (S). The virus particles are spherical in shape, and their surface glycoprotein structure allows them to specifically adsorb host cells. The serological similarity of the Jatobal virus discovered in Brazil indicates that the virus has genetic recombination characteristics. Recombinant Oropouche virus has become an important tool for studying this pathogen. These recombinant viruses constructed through reverse genetics systems allow researchers to safely study the lifecycle of viruses and host interactions under biosafety control conditions. They are widely used in neutralization testing, drug screening, and vaccine development, providing a key technological platform for developing countermeasures against this emerging infectious disease.

Transmission Routes and Prevalence Situation

Transmission Prevalence Situation	Details
Route of transmission	Vector organisms: mainly transmitted through bites of Culex pipiens (mosquitoes) and Paracoides (midges). Animal hosts: Jungle cycling hosts include three toed sloths, rodents, and various bird species.
Epidemic Situation	Brazil has confirmed 7236 cases throughout the year, with Amazon and Rondonia being high-risk areas. As of August, 14 countries including Bolivia, Colombia, and Cuba have reported confirmed cases. World's first confirmed case of death: Two female patients under the age of 30 in Bahia state, Brazil have died.
Clinical Manifestations	The typical course of the disease is divided into three stages: Acute phase (1-3 days): sudden high fever (39-40 ℃), severe headache, and retroorbital pain. Relief period (4-7 days): Symptoms temporarily subside. Recurrent period (about 30% of cases): Joint pain, rash, and neurological symptoms may occur, and severe cases may present with aseptic meningitis, but no hemorrhagic symptoms have been found yet.

Host-Virus Interactions and Target Genes

The molecular interplay between OROV and its host involves several viral proteins and host factors that are critical for the viral life cycle and the host's immune response. Understanding these interactions provides key insights for developing antiviral strategies and diagnostic tools. The table below summarizes some of the most relevant molecular targets in OROV research.

Target Name	Type	Description / Function	Research & Therapeutic Significance
Viral Glycoproteins (Gn/Gc)	Viral Protein	Surface glycoproteins encoded by the M segment, responsible for host cell receptor binding and membrane fusion.	Primary targets for neutralizing antibodies; crucial for vaccine design and serological diagnostic development.
BST-2	Host Factor	A host restriction factor that inhibits the release of viral particles from the cell surface.	Part of the compartmentalized host defense mechanism that counteracts viral proliferation; OROV may have evolved mechanisms to evade its action.
MxA GTPase	Host Factor	An interferon-induced host protein with broad antiviral activity against several RNA viruses.	A key component of the innate immune defense against bunyaviruses; its expression level can influence host susceptibility.
Type I Interferon (IFN-α/β)	Host Pathway	A critical signaling pathway for establishing an antiviral state in host cells.	OROV NSs protein specifically inhibits this pathway. Exogenous IFN-α has shown efficacy in inhibiting OROV replication in vitro, suggesting a potential therapeutic avenue.

Genomic Recombination

It is said that reclassification is one of the most important mechanisms for explaining the diversity of viruses in the Bunyavirus. When two genetically related viruses infect the same cell simultaneously to form a progeny virus, and this virus contains various components of the genetic L, M, and S fragments from the two parent viruses, this situation occurs. In recombination, S and L fragments are usually exchanged between species. Furthermore, the S fragment encoded by the nucleocapsid protein and L polymerase work together to replicate the viral genome. Therefore, one fragment will limit the molecular evolution of another fragment, which is called paired inheritance. On the contrary, M fragments encode viral glycoproteins, which are more prone to mutation due to higher selection pressure in the coding region, as these proteins are the main host range determinants.

Experiment and Research

OROV has been widely used for testing HeLa cells to investigate how it induces cell apoptosis. Research has found that OROV induces cell apoptosis through DNA fragmentation. In OROV inactivated by ultraviolet radiation, the binding of virus receptors is insufficient, requiring virus shedding and replication to induce cell apoptosis.

Conclusions

Oropouche virus represents an emerging global public health threat with a significant potential for urban outbreaks and geographic expansion. Its rapid spread, high morbidity rate, and the absence of specific countermeasures underscore the urgent need for intensified research. Current efforts are focused on understanding virus-host interactions at a molecular level, developing rapid and accurate diagnostic tests, and exploring novel antiviral strategies and vaccine candidates. Adopting a "One Health" approach that integrates human, animal, and environmental health is crucial for effective surveillance and control of this neglected pathogen.

Inquiry Basket

Loading ......

Inquiry

Target	Cat. No.	Product Name	Host
Oropouche Virus	DAGA-2014	Oropouche virus Nucleocapsid (aa 1-231) [His]	E. coli	Inquiry
	DAGA-3105	Recombinant Oropouche virus NSs [His, GST]	E. coli	Inquiry
	DAGA-3108	Recombinant Oropouche virus Gn [His]	E. coli	Inquiry